COVID-19 Update: Clinical Trials
Showing of 24 results
UH Continues to Battle COVID-19 Through Research and Clinical Trials
Clinical Trials Awareness Week 2020
Athersys and UH announce activation of first clinical site for MACOVIA study, a pivotal Phase 2/3 study evaluating Multistem® cell therapy for COVID-19 induced ARDS
UH Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients - News Release
UH to Launch Clinical Trial in the Fight to Protect Clinicians Against COVID-19
Investigational drug, ARMS-I, manufactured by ARMS Pharmaceutical may prevent airborne transmission of coronavirus - UH News Release
UH Among First in Nation to Test Investigational Antiviral Drug Against COVID-19
Clinical trials to test investigational drug remdesivir in hospitalized adults with pneumonia due to novel coronavirus - UH News Release
Obstetrics and Gynecology Clinical Trials Ongoing at University Hospitals
Trials enroll participants for menstrual, pre-eclampsia and other therapies - Innovations in Obstetrics & Gynecology | Winter 2020
Investigational Drug for Resistant Hypertension Available to UH Patients in Clinical Trial
Men and women who are taking three different types of anti-hypertension drugs without success are eligible to participate - UH Clinical Update | February 2020
Can the Polio Virus Kill Brain Tumors?
UH one of 4 sites participating in Phase II clinical trial - Innovations in Neurology & Neurosurgery | Winter 2020